Immune cells flood into the aging brain, Stanford scientists discover
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- Stanford researchers led by Julia Belk, Siddhartha Jaiswal, and Howard Chang reported in Nature that peripheral immune cells enter the human brain during aging and transform into microglia, the brain's specialized immune cells.
- The blood-to-microglia conversion begins as early as middle age, and the researchers found this process does not appear to occur in mice or non-human primates — a detail suggesting the mechanism is uniquely human.
- Scientists traced cell origins by comparing shared somatic DNA mutations between paired blood and post-mortem brain tissue samples drawn from the Stanford Rapid Autopsy Center and the University of Washington's Alzheimer's Disease Sequencing Project.
- The discovery overturns the long-standing belief that brain microglia form at birth and renew themselves throughout life without input from outside the brain, a model that held for decades.
- The team's earlier work found people carrying clones of mutated blood stem cells — a condition called clonal hematopoiesis of indeterminate potential — were much less likely to develop Alzheimer's, a clue that prompted the current investigation.
- Jaiswal said the findings suggest the life history of blood stem cells could influence the risk of brain diseases by altering microglia, opening the door to engineering peripheral immune cells to target amyloid and tau aggregates.
Why it matters: Because the blood-to-microglia conversion appears uniquely human, mouse models — the backbone of Alzheimer's and neurodegeneration research — may be missing a mechanism central to human brain aging, potentially redirecting how preclinical studies are designed. The work also reframes the aging brain as a system that exchanges cells with the body rather than a sealed compartment, expanding the surface area for future immunotherapy strategies.
Ask SkimNews
